Snowball logo
logo
6814

Lukas Biomedical Inc.

6814 β€’ TWO
NT$22.10-NT$0.90Β  (3.91%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025
Revenue
Total revenue
157.6184.8231.8189.8179.5
COGS
61.5586.8897.9476.7171.63
Gross Profit
96.0697.91133.9113.1107.9
Operating Expenses & Income
Operating Income
(43.06)(48.47)(43.56)(92.14)(81.15)
Total Operating Expenses
140.3146.5177.4205.1260.6
R&D Expenses
54.9855.9277.3394.7382.78
Selling General & Admin Expenses
30.3431.6135.4537.46106.2
Earnings from Continuing Operations
Interest Expense
(4.415)(2.92)(3.072)(3.04)(3.21)
Interest Income
0.0430.0730.090.4610.257
Income Tax Expense
1.6620.1510.078(0.095)-
Net Income
Net Income
(49.49)(50.07)(47.35)(94.38)(85.63)
Supplemental
EBIT
(43.42)(47)(44.2)(91.43)-
EBITDA
(0.361)(10.93)(12.57)(62.88)-
In millions of TWD, except % and values per 1 share